share_log

Press Release: HealthWarehouse.com Reports -2-

Press Release: HealthWarehouse.com Reports -2-

新聞稿:HealthWarehouse.com報告-2-
Dow Jones Newswires ·  2021/11/15 22:10

Adjusted EBITDA should not be considered as an alternative to net income, net loss or to net cash provided by or used in operating activities as a measure of operating results or of liquidity. It may not be comparable to similarly titled measures used by other companies, and it excludes financial information that some may consider important in evaluating the Company's performance.

調整後的EBITDA不應被視為淨收益、淨虧損或由經營活動提供或用於經營活動的淨現金的替代,以此作為衡量經營業績或流動性的指標。它可能無法與其他公司使用的類似名稱的衡量標準相比較,而且它排除了一些人可能認為對評估公司業績很重要的財務信息。

Reconciliation of Net Income (Loss) (GAAP) to Adjusted EBITDA 
(Non-GAAP)
Three Months Ended Nine Months Ended
September 30, September 30,
--------------------- ------------------------
(Unaudited) 2021 2020 2021 2020
---------- --------- ---------- ------------
Net loss $(181,031) $(15,692) $(493,866) $(177,420)
Interest
expense 43,678 45,530 130,554 160,001
Depreciation
and
amortization 34,210 33,319 100,770 100,282
-------- ------- -------- --------
EBITDA (non-GAAP) (103,143) 63,157 (262,542) 82,863
Adjustments to
EBITDA:
Stock-based
compensation 192,940 125,475 564,090 367,817
-------- ------- -------- --------
Adjusted EBITDA $ 89,797 $188,632 $ 301,548 $ 450,680
======== ======= ======== ========
淨收益(虧損)(GAAP)與調整後EBITDA的對賬(非GAAP)截至三個月截至九個月九月三十號,九月三十號,                     ---------------------  ------------------------ (未經審計)2021 2020 2021 2020                     ----------  ---------  ----------  ------------ 淨虧損$(181,031)$(15,692)$(493,866)$(177,420)利息費用43,678 45,530 130,554 160,001折舊和攤銷34,210 33,319 100,770 100,282                      --------    -------    --------    -------- EBITDA(非GAAP)(103,143)63,157(262,542)82,863調整到EBITDA:基於股票的薪酬192,940 125,475 564,090 367,817                      --------    -------    --------    -------- 調整後的EBITDA$89,797$188,632$301,548$450,680                      ========    =======    ========    ======== 

About HealthWarehouse.com

關於HealthWarehouse.com

HealthWarehouse.com, Inc. (OTCQB: HEWA), a technology company with a focus on healthcare e-commerce, sells and delivers prescription medications to all 50 states as an Approved Digital Pharmacy through the National Association of Boards of Pharmacy (NABP). HealthWarehouse.com provides a platform focused on increasing access and reducing costs of healthcare products for consumers nationwide. Based in Florence, Kentucky, the Company operates America's Leading Online Pharmacy and a pioneer in affordable healthcare. As one of the first National Association of Boards of Pharmacy ("NABP") Approved Digital Pharmacies, HealthWarehouse.com services the mission of providing affordable healthcare and incredible patient services to help Americans. Learn more at www.HealthWarehouse.com .

HealthWarehouse.com,Inc.(場外交易市場代碼:HEWA)是一家專注於保健電子商務的技術公司,通過全國藥房理事會協會(NABP)作為經批准的數字藥房向所有50個州銷售和提供處方藥。HealthWarehouse.com提供了一個平臺,專注於增加全國消費者獲得保健產品的機會並降低其成本。該公司總部設在肯塔基州佛羅倫薩,經營着美國領先的在線藥房,是負擔得起的醫療保健領域的先驅。作為首批獲得全美藥房協會(NABP)批准的數字藥房之一,HealthWarehouse.com的使命是提供負擔得起的醫療保健和令人難以置信的患者服務,幫助美國人。欲瞭解更多信息,請訪問www.HealthWarehouse.com。

Forward-Looking Statements

前瞻性陳述

This announcement and the information incorporated by reference herein contain "forward-looking statements" as defined in federal securities laws, including but not limited to Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and the Private Securities Litigation Reform Act of 1995, which statements are based on our current expectations, estimates, forecasts and projections. Statements that are not historical facts, including statements about the beliefs, expectations and future plans and strategies of the Company, are forward-looking statements. Actual results may differ materially from those expressed in forward looking statements or in management's expectations. Important factors which could cause or contribute to actual results being materially and adversely different from those described or implied by forward looking statements include, among others, risks related to competition, management of growth, access to sufficient capital to fund our business and our growth, new products, services and technologies, potential fluctuations in operating results, international expansion, outcomes of legal proceedings and claims, fulfillment center optimization, seasonality, commercial agreements, acquisitions and strategic transactions, foreign exchange rates, system interruption, cyber-attacks, access to sufficient inventory, government regulation and taxation, payments, and fraud. More information about factors that potentially could affect HealthWarehouse.com's financial results is included in HealthWarehouse.com's audited Annual Reports and Quarterly Reports available at otcmarkets.com and prior filings with the Securities and Exchange Commission.

本公告和本文引用的信息包含聯邦證券法中定義的“前瞻性陳述”,包括但不限於1933年“證券法”第27A節、1934年“證券交易法”第21E節和1995年“私人證券訴訟改革法”,這些陳述是基於我們目前的預期、估計、預測和預測作出的。“前瞻性陳述”包括但不限於1933年“證券法”第27A節、1934年“證券交易法”第21E節和1995年“私人證券訴訟改革法”。非歷史事實的陳述,包括有關公司的信念、預期以及未來計劃和戰略的陳述,均為前瞻性陳述。實際結果可能與前瞻性陳述或管理層的預期大不相同。可能導致或導致實際結果與前瞻性表述中描述或暗示的結果大不相同和不利的重要因素包括但不限於與競爭、增長管理、獲得足夠資本為我們的業務和增長提供資金、新產品、服務和技術、經營結果的潛在波動、國際擴張、法律訴訟和索賠的結果、履行中心優化、季節性、商業協議、收購和戰略交易、匯率、系統中斷、網絡攻擊、獲得足夠的庫存、政府監管和税收、支付和欺詐等相關風險。有關可能影響HealthWarehouse.com財務結果的因素的更多信息,請參見HealthWarehouse.com的審計年度報告和季度報告,這些報告可在otcmarket網站上查閲,也可在之前提交給證券交易委員會的文件中查閲。

View source version on businesswire.com: https://www.businesswire.com/news/home/20211115005223/en/

在business wire.com上查看源代碼版本:https://www.businesswire.com/news/home/20211115005223/en/

    CONTACT: 
聯繫方式:

Joseph Peters, President and CEO, (800) 748-7001

約瑟夫·彼得斯,總裁兼首席執行官,電話:(800)748-7001

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論